Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus

Virology

Volumn 350, Issue 1, 2006, Pages 192-205

  Staudt, Michelle R ^a   Dittmer, Dirk P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

K14; KSHV; LANA; ORF50; Rta; Transcription; vGPCR

Indexed keywords

GENE PRODUCT; K14 PROTEIN; LATENCY ASSOCIATED NUCLEAR ANTIGEN; PROTEIN GPCR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA BINDING MOTIF; EMBRYO; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; NONHUMAN; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; VIRUS REACTIVATION;

ANTIGENS, VIRAL; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; MUTATION; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

EID: 33745033994     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.03.006     Document Type: Article

References (73)

1. An J., Sun Y., Sun R., and Rettig M.B. Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways. Oncogene 22 22 (2003) 3371-3385
2. Ballestas M.E., Chatis P.A., and Kaye K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284 5414 (1999) 641-644
3. Bechtel J.T., Winant R.C., and Ganem D. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79 8 (2005) 4952-4964
4. Bieleski L., and Talbot S.J. Kaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry site. J. Virol. 75 4 (2001) 1807-1864
5. Cai X., Lu S., Zhang Z., Gonzalez C.M., Damania B., and Cullen B.R. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl. Acad. Sci. U.S.A. 102 15 (2005) 5570-5575
6. Chang P.J., and Miller G. Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein. J. Virol. 78 19 (2004) 10657-10673
7. Chang P.J., Shedd D., and Miller G. Two subclasses of Kaposi's sarcoma-associated herpesvirus lytic cycle promoters distinguished by open reading frame 50 mutant proteins that are deficient in binding to DNA. J. Virol. 79 14 (2005) 8750-8763
8. Chang Y., Moore P.S., Talbot S.J., Boshoff C.H., Zarkowska T., Godden K., Paterson H., Weiss R.A., and Mittnacht S. Cyclin encoded by KS herpesvirus. Nature 382 6590 (1996) 410
9. Chen J., Ueda K., Sakakibara S., Okuno T., Parravicini C., Corbellino M., and Yamanishi K. Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc. Natl. Acad. Sci. U.S.A. 98 7 (2001) 4119-4124
10. Chiou C.J., Poole L.J., Kim P.S., Ciufo D.M., Cannon J.S., ap Rhys C.M., Alcendor D.J., Zong J.C., Ambinder R.F., and Hayward G.S. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J. Virol. 76 7 (2002) 3421-3439
11. Cotter M.A., and Robertson E.S. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264 2 (1999) 254-264
12. Damania B., Jeong J.H., Bowser B.S., DeWire S.M., Staudt M.R., and Dittmer D.P. Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesvirus es. J. Virol. 78 10 (2004) 5491-5499
13. Dittmer D.P. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res. 63 9 (2003) 2010-2015
14. Dittmer D., Lagunoff M., Renne R., Staskus K., Haase A., and Ganem D. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J. Virol. 72 10 (1998) 8309-8315
15. Dittmer D., Stoddart C., Renne R., Linquist-Stepps V., Moreno M.E., Bare C., McCune J.M., and Ganem D. Experimental Transmission of Kaposi's Sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv Mice. J. Exp. Med. 190 12 (1999) 1857-1868
16. Dupin N., Fisher C., Kellam P., Ariad S., Tulliez M., Franck N., van Marck E., Salmon D., Gorin I., Escande J.P., Weiss R.A., Alitalo K., and Boshoff C. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. U.S.A. 96 8 (1999) 4546-4551
17. Fakhari F.D., and Dittmer D.P. Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J. Virol. 76 12 (2002) 6213-6223
18. Field N., Low W., Daniels M., Howell S., Daviet L., Boshoff C., and Collins M. KSHV vFLIP binds to IKK-gamma to activate IKK. J. Cell Sci. 116 Pt 18 (2003) 3721-3728
19. Friborg Jr. J., Kong W., Hottiger M.O., and Nabel G.J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402 6764 (1999) 889-894
20. Fujimuro M., Wu F.Y., ApRhys C., Kajumbula H., Young D.B., Hayward G.S., and Hayward S.D. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9 3 (2003) 300-306
21. Garber A.C., Shu M.A., Hu J., and Renne R. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75 17 (2001) 7882-7892
22. Garber A.C., Hu J., and Renne R. Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J. Biol. Chem. 277 30 (2002) 27401-27411
23. Godfrey A., Anderson J., Papanastasiou A., Takeuchi Y., and Boshoff C. Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 105 6 (2005) 2510-2518
24. Greger I.H., and Proudfoot N.J. Poly(A) signals control both transcriptional termination and initiation between the tandem GAL10 and GAL7 genes of Saccharomyces cerevisiae. EMBO J. 17 16 (1998) 4771-4779
25. Greger I.H., Demarchi F., Giacca M., and Proudfoot N.J. Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter. Nucleic Acids Res. 26 5 (1998) 1294-1301
26. Grundhoff A., and Ganem D. Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75 4 (2001) 1857-1863
27. Grundhoff A., and Ganem D. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest. 113 1 (2004) 124-136
28. Guasparri I., Keller S.A., and Cesarman E. KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199 7 (2004) 993-1003
29. Herndier B.G., Werner A., Arnstein P., Abbey N.W., Demartis F., Cohen R.L., Shuman M.A., and Levy J.A. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS 8 5 (1994) 575-581
30. Hu J., Garber A.C., and Renne R. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J. Virol. 76 22 (2002) 11677-11687
31. Jenner R.G., Alba M.M., Boshoff C., and Kellam P. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J. Virol. 75 2 (2001) 891-902
32. Jeong J., Papin J., and Dittmer D. Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters. J. Virol. 75 4 (2001) 1798-1807
33. Jeong J.H., Hines-Boykin R., Ash J.D., and Dittmer D.P. Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice. J. Virol. 76 21 (2002) 11024-11032
34. Jeong J.H., Orvis J., Kim J.W., McMurtrey C.P., Renne R., and Dittmer D.P. Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Biol. Chem. 279 16 (2004) 16822-16831
35. Kedes D.H., Lagunoff M., Renne R., and Ganem D. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J. Clin. Invest. 100 10 (1997) 2606-2610
36. Kellam P., Boshoff C., Whitby D., Matthews S., Weiss R.A., and Talbot S.J. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J. Hum. Virol. 1 1 (1997) 19-29
37. Komanduri K.V., Luce J.A., McGrath M.S., Herndier B.G., and Ng V.L. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 13 3 (1996) 215-226
38. Krishnan H.H., Naranatt P.P., Smith M.S., Zeng L., Bloomer C., and Chandran B. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 78 7 (2004) 3601-3620
39. Krithivas A., Young D.B., Liao G., Greene D., and Hayward S.D. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J. Virol. 74 20 (2000) 9637-9645
40. Krithivas A., Fujimuro M., Weidner M., Young D.B., and Hayward S.D. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J. Virol. 76 22 (2002) 11596-11604
41. Lan K., Kuppers D.A., Verma S.C., and Robertson E.S. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J. Virol. 78 12 (2004) 6585-6594
42. Lan K., Kuppers D.A., and Robertson E.S. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway. J. Virol. 79 6 (2005) 3468-3478
43. Lan K., Kuppers D.A., Verma S.C., Sharma N., Murakami M., and Robertson E.S. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J. Virol. 79 12 (2005) 7453-7465
44. Li H., Komatsu T., Dezube B.J., and Kaye K.M. The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J. Virol. 76 23 (2002) 11880-11888
45. Liang Y., and Ganem D. RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA. J. Virol. 78 13 (2004) 6818-6826
46. Lim C., Sohn H., Gwack Y., and Choe J. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity [In Process Citation]. J. Gen. Virol. 81 Pt 11 (2000) 2645-2652
47. Lim C., Gwack Y., Hwang S., Kim S., and Choe J. The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Biol. Chem. 276 33 (2001) 31016-31022
48. Lu F., Zhou J., Wiedmer A., Madden K., Yuan Y., and Lieberman P.M. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J. Virol. 77 21 (2003) 11425-11435
49. Lukac D.M., Kirshner J.R., and Ganem D. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73 11 (1999) 9348-9361
50. Lunardi-Iskandar Y., Bryant J.L., Zeman R.A., Lam V.H., Samaniego F., Besnier J.M., Hermans P., Thierry A.R., Gill P., and Gallo R.C. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375 6526 (1995) 64-68
51. Matsumura S., Fujita Y., Gomez E., Tanese N., and Wilson A.C. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). J. Virol. 79 13 (2005) 8493-8505
52. Mesri E.A., Cesarman E., Arvanitakis L., Rafii S., Moore M.A., Posnett D.N., Knowles D.M., and Asch A.S. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J. Exp. Med. 183 5 (1996) 2385-2390
53. Moore P.S., and Chang Y. Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis. J. Natl. Cancer Inst. Monogr. 23 (1998) 65-71
54. Nicholas J., Zong J.C., Alcendor D.J., Ciufo D.M., Poole L.J., Sarisky R.T., Chiou C.J., Zhang X., Wan X., Guo H.G., Reitz M.S., and Hayward G.S. Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8. J. Natl. Cancer Inst. Monogr. 23 (1998) 79-88
55. Paulose-Murphy M., Ha N.K., Xiang C., Chen Y., Gillim L., Yarchoan R., Meltzer P., Bittner M., Trent J., and Zeichner S. Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J. Virol. 75 10 (2001) 4843-4853
56. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grasser F.A., van Dyk L.F., Ho C.K., Shuman S., Chien M., Russo J.J., Ju J., Randall G., Lindenbach B.D., Rice C.M., Simon V., Ho D.D., Zavolan M., and Tuschl T. Identification of microRNAs of the herpesvirus family. Nat. Methods 2 4 (2005) 269-276
57. Radkov S.T., Kellam P., and Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 6 10 (2000) 1121-1127
58. Rainbow L., Platt G., Simpson G., Sarid R., Gao S., Stoiber H., Herrington C., Moore P., and Schulz T. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J. Virol. 71 8 (1997) 5915-5921
59. Renne R., Barry C., Dittmer D., Compitello N., Brown P.O., and Ganem D. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75 1 (2001) 458-468
60. Roizman B. Herpesviriddae. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Virology vol. 2 (1996), Lippincott-Raven, Philadelphia 2221-2230 (2 vols.)
61. Russo J.J., Bohenzky R.A., M.-C. C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Y. C., and Moore P.S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. U.S.A. 93 25 (1996) 14862-14867
62. Sadler R., Wu L., Forghani B., Renne R., Zhong W., Herndier B., and Ganem D. A complex translational program generates multiple novel proteins from the latently expressed Kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73 7 (1999) 5722-5730
63. Samols M.A., Hu J., Skalsky R.L., and Renne R. Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79 14 (2005) 9301-9305
64. Sarid R., Flore O., Bohenzky R.A., Chang Y., and Moore P.S. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J. Virol. 72 2 (1998) 1005-1012
65. Sarid R., Wiezorek J.S., Moore P.S., and Chang Y. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J. Virol. 73 2 (1999) 1438-1446
66. Song M.J., Deng H., and Sun R. Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus /human herpesvirus 8. J. Virol. 77 17 (2003) 9451-9462
67. Szekely l., Kiss C., Mattsson K., Kashuba E., Pokrovskaja K., Juhasz A., Holmvall P., and Klein G. Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin-associated nuclear bodies. J. Gen. Virol. 80 (1999) 2889-2900
68. Talbot S.J., Weiss R.A., Kellam P., and Boshoff C. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 257 1 (1999) 84-94
69. Verma S.C., Borah S., and Robertson E.S. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J. Virol. 78 19 (2004) 10348-10359
70. Wong L.Y., Matchett G.A., and Wilson A.C. Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif. J. Virol. 78 18 (2004) 10074-10085
71. Ye F.C., Zhou F.C., Yoo S.M., Xie J.P., Browning P.J., and Gao S.J. Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence. J. Virol. 78 20 (2004) 11121-11129
72. Yoo S.M., Zhou F.C., Ye F.C., Pan H.Y., and Gao S.J. Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells. Virology 343 1 (2005) 47-64
73. Zhong W., Wang H., Herndier B., and Ganem D. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc. Natl. Acad. Sci. U.S.A. 93 13 (1996) 6641-6646